RECRUITING

Employment Support After Hematopoietic Stem Cell Transplantation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Official Title

Supportive Care Intervention Development to Address Employment Concerns After Allogeneic Hematopoietic Stem Cell Transplantation

Quick Facts

Study Start:2024-07-31
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06494423

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Received an allogeneic HSCT within the past six months to treat a hematological malignancy.
  2. * Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?")
  1. * Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures
  2. * We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.

Contacts and Locations

Study Contact

Kathleen Lyons, ScD, OTR/L
CONTACT
614-643-5372
klyons2@mghihp.edu

Principal Investigator

Kathleen Lyons, ScD, OTR/L
PRINCIPAL_INVESTIGATOR
MGH Institute of Health Professions

Study Locations (Sites)

MGH Cancer Center
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: MGH Institute of Health Professions

  • Kathleen Lyons, ScD, OTR/L, PRINCIPAL_INVESTIGATOR, MGH Institute of Health Professions

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-31
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-07-31
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Return to Work

Additional Relevant MeSH Terms

  • Hematopoietic Stem Cell Transplantation